Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:cyclooxygenase 1 inhibitor
go back to main search page
Accession:CHEBI:50630 term browser browse the term
Definition:A cyclooxygenase inhibitor that interferes with the action of cyclooxygenase 1.
Synonyms:related_synonym: COX-1 inhibitor;   COX-1 inhibitors;   PTGS1 inhibitor;   PTGS1 inhibitors;   cyclo-oxygenase 1 inhibitor;   cyclo-oxygenase 1 inhibitors;   cyclooxygenase-1 inhibitors;   prostaglandin G/H synthase 1 inhibitor;   prostaglandin G/H synthase 1 inhibitors;   prostaglandin H2 synthase 1 inhibitor;   prostaglandin H2 synthase 1 inhibitors;   prostaglandin-endoperoxide synthase 1 inhibitor;   prostaglandin-endoperoxide synthase 1 inhibitors
 xref: Wikipedia:PTGS1


show annotations for term's descendants       view all columns           Sort by:
 





Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19654
    role 19598
      biological role 19596
        biochemical role 19125
          enzyme inhibitor 17962
            EC 1.* (oxidoreductase) inhibitor 16355
              EC 1.14.* (oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor 14183
                EC 1.14.99.* (miscellaneous oxidoreductase acting on paired donors, with incorporation or reduction of molecular oxygen) inhibitor 12492
                  EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor 12492
                    cyclooxygenase 1 inhibitor 10903
                      (+)-conocarpan 0
                      (+)-epicatechin + 50
                      (-)-larreatricin 0
                      (2S,3S)-2,3-dihydro-3-hydroxymethyl-2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran 0
                      (S)-ketorolac + 19
                      1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone 0
                      13,14,15,16-tetranorlabdane-8alpha,12,18-triol 0
                      2-(2,4-dihydroxyphenyl)-5-(E)-propenylbenzofuran 0
                      2-(2-hydroxy-4-methoxyphenyl)-5-(3-hydroxypropyl)benzofuran 0
                      2-(4-hydroxyphenyl)-5-(E)-propenylbenzofuran 0
                      5-(3-hydroxypropyl)-2-(2-methoxy-4-hydroxyphenyl)benzofuran 0
                      8alpha,19-dihydroxylabd-13E-ene-15-oic acid 0
                      SC560 0
                      acetylsalicylic acid + 648
                      amfenac + 2
                      amfenac sodium hydrate 0
                      centaureidin 0
                      dexketoprofen 0
                      droxicam 0
                      fenoprofen 16
                      fenoprofen calcium 0
                      fenoprofen calcium (anhydrous) + 0
                      fomitopinic acid A 0
                      fomitoside E 0
                      fomitoside F 0
                      ibuprofen + 289
                      ipomotaoside A 0
                      ketorolac 19
                      ketorolac tromethamine 0
                      lupulin A 0
                      meso-3,3'-didemethoxynectandrin B 0
                      multifidol glucoside 0
                      myricetin + 107
                      naproxen + 105
                      naproxen sodium 0
                      nepafenac 0
                      nitroflurbiprofen 7
                      oleocanthal 0
                      paracetamol + 10642
                      piroxicam + 587
                      quercetin 4'-O-alpha-L-rhamnopyranosyl-3-O-beta-D-allopyranoside 0
                      rataniaphenol I 0
                      rataniaphenol II 0
                      rataniaphenol III 0
                      sodium (2-amino-3-benzoylphenyl)acetate + 0
                      sophoraisoflavanone A 0
                      valerylsalicylic acid 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.